In clinical trials, individuals using tirzepatide for weight loss have seen an average weight reduction of 15% to 21% of their starting body weight over approximately 72 weeks
Glutathione IV therapy delivers this compound directly into the bloodstream, allowing higher concentrations to circulate at the cellular level than oral supplementation typically allows
Bottom line: While early evidence and user reports are promising, 5-Amino-1MQ remains an experimental research compound
"Losing weight has a tendency to improve body image, self-esteem, and even mobilitythese are all things that help with mental health," Thea Gallagher, PsyD, clinical associate professor of psychology at NYU Langone Health, tells SELF
One possibility is that the difference in efficiency in weight loss is due to a higher uptake of liraglutide in the CNS